Live Breaking News & Updates on Ryan Hartwell

Stay updated with breaking news from Ryan hartwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury


his potential treatment opportunity was confirmed by the company s bioinformatics platform, PsyCollage
VANCOUVER, BC, March 4, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (
MINDCURE or the
Company ) a leader in developing technology to advance psychedelic-related treatments, is pleased to announce that the Company s bioinformatics platform,
PsyCollage, has identified opportunities for ibogaine to support neuroregenerative pathways that the Company believes could be pivotal in treating neuropathic pain and brain trauma.
Ibogaine is a psychoactive substance extracted from the iboga shrub native to West Africa. Contributing to its powerful anti-addiction actions, ibogaine is associated with increases in the levels of brain neurotrophic factors, particularly GDNF and BDNF, which have potent neuroregenerative and neuroprotective properties. ....

British Columbia , Thomas Brown , Soledad Marton , Kelsey Ramsden , Ryan Hartwell , Cure Health , Company Psycollage , Ibogaine Administration Modifies , Health Canada , Cure Health Inc , Mind Cure Health , West African , Prescription Drug List , Administration Modifies , Brain Regions Involved , Nigral Dopaminergic Circuits , Substance Dependence , Drug Abuse Reviews , Chief Scientific Officer , Mind Cure Health Inc , Medical Pharmaceuticals , Health Care Amp Hospitals , Small Cap , Mental Health , Mobile Entertainment , Telecommunications Industry ,

Mind Cure Health : MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research


The Company expects to have ibogaine manufactured and in use for research by Q4.
VANCOUVER, BC, March 3, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (
MINDCURE or the
Company ) a leader in advanced proprietary technology for psychedelic drug discovery, is pleased to announce that it has begun the first stage of manufacturing pharmaceutical grade ibogaine to be used in preclinical and clinical research.
Ibogaine is a naturally occurring psychoactive compound extracted from the root of the
Tabernanthe iboga shrub
, native of the Congo and Gabon.
1 The compound offers therapeutic potential for substance use disorders, and is claimed to be among the most powerful anti-addiction drugs, particularly when used with proper supervision and support. However, natural sources of ibogaine are extremely limited since these plants are at risk of extinction due to the growing global demand and environmental pressures threatenin ....

British Columbia , Ignacio Carrera , Kelsey Ramsden , Soledad Marton , Ryan Hartwell , Cure Health , Ibogaine Administration Modifies , Cure Health Inc , Mind Cure Health , Chief Science Officer , Psychedelic Ibogaine May Heal , Administration Modifies , Brain Regions Involved , Nigral Dopaminergic Circuits , Mind Cure Health Inc Stock Exchange , Press Release , Advanced 6mh , பிரிட்டிஷ் கொலம்பியா , இக்ந்யாஸியொ கரேரா , கெல்ஸீ ராம்ஸ்டன் , சோலேதத் மார்டன் , ரியான் ஹார்ட்வெல் , குணப்படுத்த ஆரோக்கியம் , குணப்படுத்த ஆரோக்கியம் இன்க் , மனம் குணப்படுத்த ஆரோக்கியம் , தலைமை அறிவியல் அதிகாரி ,

Mind Cure Comments on Recent Promotional Activity


Mind Cure Comments on Recent Promotional Activity
News provided by
Share this article
Mind Cure or the
Company ) (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) has been asked by OTC Markets Group Inc. (
OTC Markets ) to comment on recent promotional activity concerning its common shares traded on the OTCQB.
On February 11, 2021, OTC Markets sent the Company copies of two articles (the
Articles ) purportedly distributed by National Inflation Association (
NIA ). The Company was not aware of the Articles until the OTC Markets sent a copy of them to the Company on February 11, 2021.
The Company does not believe the promotional activities were a factor in the recent increase in trading volume in the Company s common shares on the OTCQB which occurred beginning on or about February 10, 2021. Instead, the Company attributes the increase to the announcement on February 10, 2021 that the Company closed a C$23 million bought deal offering (the ....

British Columbia , Kelsey Ramsden , Kelly Ramsden , Ryan Hartwell , National Inflation Association , Jack Taylor Corporation , Sandstone Media Inc , Oak Hill Financial Inc , Group Inc , Company On , Capital Corp , Cure Health Inc , Rallen Digital , Cure Health , Sandstone Media , Psychedlic Finance , Oak Hill Financial , Chief Executive , Mind Cure Health Inc , Medical Pharmaceuticals , Health Care Amp Hospitals , Small Cap , Mental Health , பிரிட்டிஷ் கொலம்பியா , கெல்ஸீ ராம்ஸ்டன் , கெல்லி ராம்ஸ்டன் ,